Several illnesses that are chronic and acute are becoming more relevant as the world’s aging population expands, and the medical sector is transforming rapidly, as a consequence of which the need for “point-of-care” (POC), identification/detection, and real time management of health issues that have been required for a long time are increasing. Biomarkers are biological markers that help to detect status of health or disease. Biosensors’ applications are for screening for early detection, chronic disease treatment, health management, and well-being surveillance. Smart devices that allow continual monitoring of vital biomarkers for physiological health monitoring, medical diagnosis, and assessment are becoming increasingly widespread in a variety of applications, ranging from biomedical to healthcare systems of surveillance and monitoring. The term “smart” is used due to the ability of these devices to extract data with intelligence and in real time. Wearable, implantable, ingestible, and portable devices can all be considered smart devices; this is due to their ability of smart interpretation of data, through their smart sensors or biosensors and indicators. Wearable and portable devices have progressed more and more in the shape of various accessories, integrated clothes, and body attachments and inserts. Moreover, implantable and ingestible devices allow for the medical diagnosis and treatment of patients using tiny sensors and biomedical gadgets or devices have become available, thus increasing the quality and efficacy of medical treatments by a significant margin. This article summarizes the state of the art in portable, wearable, ingestible, and implantable devices for health status monitoring and disease management and their possible applications. It also identifies some new technologies that have the potential to contribute to the development of personalized care. Further, these devices are non-invasive in nature, providing information with accuracy and in given time, thus making these devices important for the future use of humanity.

Xanthine oxidase (XOD) extracted from bovine milk was immobilized covalently via N-ethyl-N′-(3-dimethylaminopropyl)carbodiimide (EDC) and N-hydroxy succinimide (NHS) chemistry onto cadmium oxide nanoparticles (CdO)/carboxylated multiwalled carbon nanotube (c-MWCNT) composite film electrodeposited on the surface of an Au electrode. The nanocomposite modified Au electrode was characterized by Fourier transform infrared (FTIR), cyclic voltammetry (CV), scanning electron microscopy (SEM) and electrochemical impedance spectroscopy (EIS) before and after immobilization of XOD. Under optimal operation conditions (25 °C, +0.2 V vs. Ag/AgCl, sodium phosphate buffer, pH 7.5), the following characteristics are attributed to the biosensor: linearity of response up to xanthine concentrations of 120 μM, detection limit of 0.05 μM (S/N = 3) and a response time of at most 4 s. After being used 100 times over a period of 120 days, only 50% loss of the initial activity of the biosensor was evaluated when stored at 4 °C. The fabricated biosensor was successfully employed for the determination of xanthine in fish meat.

Antioxidants are first line defence system against free radical damage and play very crucial role in maintaining optimum health care. Although, present day research is focused on the potential and miraculous benefits of antioxidant nutrients or supplements in our daily life. It has become the best protection against oxidative stress involve a wide selection of interrelated antioxidants and antioxidant cofactors. In addition, the combination of several suboptimal concentrations of these kinds of detoxifying supplements may also have an additive or even synergistic role to decrease the risk of some of common and lethal diseases which caused due to aging. Adequate intake of antioxidants, such as beta-carotene and vitamin C supplements or some of fruit and vegetables which have been reported as essential antioxidants which play a vital role in decreasing the risk of cancer and coronary heart disease (CHD).